Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Been looking at life sciences ETF options lately and wanted to share what caught my eye. So if you're thinking about getting exposure to healthcare and biotech without picking individual stocks, these funds are worth checking out. The beauty of a life science ETF is you get instant diversification across the sector. I found that SPDR Biotech (XBI) had solid year-to-date performance at 16.8%, managing around $7.82B in assets. It's been around since 2006 and tracks biotech companies pretty closely. Then there's Vanguard Health Care Index Fund (VHT) which is broader - covers the whole healthcare space with 414 holdings. Not the flashiest returns at 11.9% YTD, but the expense ratio is incredibly low at 0.1%, so you're not bleeding money on fees. If medical devices are more your thing, iShares US Medical Devices ETF (IHI) has been steady too, around 11.7% gains this year. What I noticed is that most of these life sciences ETF picks are dominated by large-cap companies - which makes sense for stability but limits upside. First Trust's biotech fund (FBT) is smaller and more concentrated if you want something different. The key thing about choosing a life science ETF is knowing whether you want broad healthcare exposure or something more specialized like pure biotech. Depends on your risk appetite, honestly.